It is standard practice for scientists and drug companies to use synthetic psilocybin formulas when conducting clinical studies or drug trials. But synthetic psilocybin is now also showing up outside ...
TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback